CIK 0001701108
- Non-accelerated filer
- Smaller reporting company
Spero Therapeutics, Inc.
Sign in to watch- Ticker
- SPRO
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- Phone
- +1 857-242-1600
- Business address
- 675 MASSACHUSETTS AVENUE, 14TH FLOOR, CAMBRIDGE, MA, 02139
- Former names
- Spero Therapeutics, LLC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $42,485
- in 1 filing
Net −$42,485. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2020-10-14 | Mahadevia Ankit CEO and President | Exercise or conversion | +105 | $5.90 | $620 | 65,922 |
| 2020-10-14 | Mahadevia Ankit CEO and President | Sale | −105 | $14.25 | $1K | 65,817 |
| 2020-10-14 | Mahadevia Ankit CEO and President | Exercise or conversion · Stock Option (Right to Buy) | −105 | 504,336 | ||
| 2020-10-13 | Mahadevia Ankit CEO and President | Exercise or conversion | +14,367 | $5.90 | $85K | 80,184 |
| 2020-10-13 | Mahadevia Ankit CEO and President | Sale | −14,367 | $14.28 | $205K | 65,817 |
| 2020-10-13 | Mahadevia Ankit CEO and President | Exercise or conversion · Stock Option (Right to Buy) | −14,367 | 504,441 | ||
| 2020-09-08 | Mahadevia Ankit CEO and President | Exercise or conversion | +774 | $5.90 | $5K | 66,591 |
| 2020-09-08 | Mahadevia Ankit CEO and President | Sale | −774 | $14.25 | $11K | 65,817 |
| 2020-09-08 | Mahadevia Ankit CEO and President | Exercise or conversion · Stock Option (Right to Buy) | −774 | 518,808 | ||
| 2020-07-09 | Mahadevia Ankit CEO and President | Exercise or conversion | +2,293 | $5.90 | $14K | 68,110 |
| 2020-07-09 | Mahadevia Ankit CEO and President | Sale | −2,293 | $14.31 | $33K | 65,817 |
| 2020-07-09 | Mahadevia Ankit CEO and President | Exercise or conversion · Stock Option (Right to Buy) | −2,293 | 519,582 | ||
| 2020-07-07 | Mahadevia Ankit CEO and President | Exercise or conversion | +754 | $5.90 | $4K | 66,571 |
| 2020-07-07 | Mahadevia Ankit CEO and President | Sale | −754 | $14.25 | $11K | 65,817 |
| 2020-07-07 | Mahadevia Ankit CEO and President | Exercise or conversion · Stock Option (Right to Buy) | −754 | 521,875 | ||
| 2020-06-25 | Mahadevia Ankit CEO and President | Exercise or conversion | +2,642 | $5.90 | $16K | 68,459 |
| 2020-06-25 | Mahadevia Ankit CEO and President | Sale | −2,642 | $14.25 | $38K | 65,817 |
| 2020-06-25 | Mahadevia Ankit CEO and President | Exercise or conversion · Stock Option (Right to Buy) | −2,642 | 522,629 | ||
| 2020-06-24 | Mahadevia Ankit CEO and President | Exercise or conversion | +3,880 | $5.90 | $23K | 69,697 |
| 2020-06-24 | Mahadevia Ankit CEO and President | Sale | −3,880 | $14.28 | $55K | 65,817 |
Page 12 of 17 · 340 trades